Verastem, Inc. (VSTM) Social Stream
Featured Post From StockTwits About VSTM
$VSTM Verastem is very well positioned to be acquired. It has a "necessary" drug. Consensus among those in the know is that huge DATA is due. I acquiesce, and will go one more to say it puts them in a power position in a "Buyout". Receivables, (330M deal with royalties), Strong Pipeline, FDA Breakthrough Designation, (which is noteworthy, especially now), and Cash Runway till 2024, plus CASH. What's not to love. This is not a $3 stock.ChartHawk, published August 4, 2021
Suitor are in wait.
What Else are VSTM Traders Talking About?
Other tickers frequently mentioned alongside VSTM is SAVA.
Other Notable StockTweets About VSTM
$VSTM Can Verastem VSTM have a strong upward price move ... ?
Here is an example - Cassava Sciences - $SAVA
Here is SAVA Price & Volume Chart since September 2020 ...
January to February 2021 from $10 to over $100
in April 2021 back down to low $30's
April 2021 to July 2021 back up to $100 to $120 / share ...
@LonoTrader @TMessi @CrozrX
$VSTM Resistance levels that need to be dealt with. We need 10 min closes above 3.56, 3.62 and 3.70. Getting above, and staying above 3.62 today is a good aggressive goal.1baddude2, published July 16, 2021
$VSTM If the Baker Boys and the like are here, the only reason it would pull back hard off $5, is they know the Tutes are coming in on the walls, and they are collecting more. This is not a $3.77 stock. Significant Cash Runway, 330M deal with residuals, FDA ODD Granted, pipeline & future revenue = $20-$50 easily. This is artificially depressed. Not even at intrinsic. LOAD WITH CONFIDENCE.ChartHawk, published July 9, 2021
$VSTM It is really easy to get distracted by the daily gyrations of bios, VSTM included. Consider how many new inexperienced Robinhood day-traders, algos, and MM's manipulate the price. None of this has anything to do with future success or commercial viability. That volatility tends to express across the entire universe of start-ups, so try not to get too wigged out.JCMV, published July 3, 2021